A very large percentage of all of these patient segments are currently ... of ZORYVE foam to help patients with scalp and ...

Organon is a strong investment opportunity with a high yield, diversified portfolio, steady performance, and transformative ...

Stationary plaque psoriasis, which is usually a chronic illness ... distal interphalangeal [DIP] arthritis), but sometimes also individual large joints (oligoarthritis). About 40% of patients ...

Study authors examined the use of artificial intelligence in machine learning models for the assessment of psoriasis severity, as well as identified future research needs.

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

Patients with plaque psoriasis treated with Johnson & Johnson ... Click here for more. In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies ...

In plaque psoriasis, PONVORY has shown significant efficacy in achieving PASI 75, a measurement of improvement of psoriasis score by week 16 in a large 326 patient study that included two doses of ...

The National Institute for Health and Care Excellence (NICE) has backed the use of the first-in-class Tyk2 inhibitor as an option for treating adults with moderate to severe plaque psoriasis who ...

One woman’s journey from receiving her diagnosis to finding a treatment that helps manage her chronic skin condition.

Researchers conducted a retrospective study to investigate the effectiveness of brodalumab for treating difficult-to-manage ...

MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritisTwo trials for ...